Does the media prefer TMO or ILMN?

In the previous week, Thermo Fisher Scientific had 3 more articles in the media than Illumina. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 33 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.29 beat Illumina's score of 0.45 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 28 Very Positive mention(s) 6 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 14 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media prefer TMO or MEDP?

In the previous week, Thermo Fisher Scientific had 31 more articles in the media than Medpace. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 5 mentions for Medpace. Medpace's average media sentiment score of 1.29 beat Thermo Fisher Scientific's score of 1.29 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 28 Very Positive mention(s) 6 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TMO or A?

In the previous week, Thermo Fisher Scientific had 24 more articles in the media than Agilent Technologies. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 12 mentions for Agilent Technologies. Thermo Fisher Scientific's average media sentiment score of 1.29 beat Agilent Technologies' score of 0.52 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 28 Very Positive mention(s) 6 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer TMO or AMN?

In the previous week, Thermo Fisher Scientific had 15 more articles in the media than AMN Healthcare Services. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 21 mentions for AMN Healthcare Services. Thermo Fisher Scientific's average media sentiment score of 1.29 beat AMN Healthcare Services' score of 0.52 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 28 Very Positive mention(s) 6 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 5 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TMO or BIO?

In the previous week, Thermo Fisher Scientific had 25 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 11 mentions for Bio-Rad Laboratories. Thermo Fisher Scientific's average media sentiment score of 1.29 beat Bio-Rad Laboratories' score of 0.33 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 28 Very Positive mention(s) 6 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Rad Laboratories 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Thermo Fisher Scientific (TMO) Competitors

$699.98 +0.54 (+0.08%)

Closing price 03:59 PM Eastern

Extended Trading

$699.50 -0.48 (-0.07%)

As of 06:27 PM Eastern

Compare

TMO vs. ILMN, MEDP, A, AMN, and BIO

Should you buy Thermo Fisher Scientific stock or one of its competitors? Thermo Fisher Scientific's main competitors and comparable companies include Illumina (ILMN), Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), and Bio-Rad Laboratories (BIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Thermo Fisher Scientific compare to Illumina?

Thermo Fisher Scientific (NYSE:TMO) and Illumina (NASDAQ:ILMN) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

In the previous week, Thermo Fisher Scientific had 3 more articles in the media than Illumina. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 33 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.29 beat Illumina's score of 0.45 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	28 Very Positive mention(s)	6 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	14 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral

Thermo Fisher Scientific presently has a consensus target price of $683.64, indicating a potential downside of 2.27%. Illumina has a consensus target price of $244.24, indicating a potential upside of 16.55%. Given Illumina's higher probable upside, analysts clearly believe Illumina is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	2 Strong Buy rating(s)	2.93
Illumina	3 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.37

Illumina has a net margin of 19.72% compared to Thermo Fisher Scientific's net margin of 14.94%. Illumina's return on equity of 28.38% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	14.94%	17.33%	8.18%
Illumina	19.72%	28.38%	12.11%

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 2.9% of Illumina shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Thermo Fisher Scientific has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.82	$6.70B	$18.96	36.90
Illumina	$4.34B	7.30	$850M	$5.81	36.07

Thermo Fisher Scientific has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, Illumina has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market.

Summary

Illumina beats Thermo Fisher Scientific on 9 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Medpace?

Thermo Fisher Scientific (NYSE:TMO) and Medpace (NASDAQ:MEDP) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

In the previous week, Thermo Fisher Scientific had 31 more articles in the media than Medpace. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 5 mentions for Medpace. Medpace's average media sentiment score of 1.29 beat Thermo Fisher Scientific's score of 1.29 indicating that Medpace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	28 Very Positive mention(s)	6 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medpace	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific presently has a consensus price target of $683.64, indicating a potential downside of 2.27%. Medpace has a consensus price target of $649.27, indicating a potential downside of 1.15%. Given Medpace's higher probable upside, analysts clearly believe Medpace is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	2 Strong Buy rating(s)	2.93
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23

Thermo Fisher Scientific has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market. Comparatively, Medpace has a beta of 1.12, indicating that its share price is 12% more volatile than the broader market.

Medpace has a net margin of 18.24% compared to Thermo Fisher Scientific's net margin of 14.94%. Medpace's return on equity of 99.76% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	14.94%	17.33%	8.18%
Medpace	18.24%	99.76%	24.47%

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by company insiders. Comparatively, 20.5% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Thermo Fisher Scientific has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.82	$6.70B	$18.96	36.90
Medpace	$2.53B	7.26	$451.12M	$18.04	36.41

Summary

Medpace beats Thermo Fisher Scientific on 9 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Agilent Technologies?

Thermo Fisher Scientific (NYSE:TMO) and Agilent Technologies (NYSE:A) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Thermo Fisher Scientific has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, Agilent Technologies has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

In the previous week, Thermo Fisher Scientific had 24 more articles in the media than Agilent Technologies. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 12 mentions for Agilent Technologies. Thermo Fisher Scientific's average media sentiment score of 1.29 beat Agilent Technologies' score of 0.52 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	28 Very Positive mention(s)	6 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilent Technologies	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Thermo Fisher Scientific has higher revenue and earnings than Agilent Technologies. Agilent Technologies is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.82	$6.70B	$18.96	36.90
Agilent Technologies	$6.95B	7.03	$1.30B	$5.08	34.09

Thermo Fisher Scientific pays an annual dividend of $1.88 per share and has a dividend yield of 0.3%. Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.6%. Thermo Fisher Scientific pays out 9.9% of its earnings in the form of a dividend. Agilent Technologies pays out 20.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Thermo Fisher Scientific has raised its dividend for 8 consecutive years and Agilent Technologies has raised its dividend for 9 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Agilent Technologies has a net margin of 19.53% compared to Thermo Fisher Scientific's net margin of 14.94%. Agilent Technologies' return on equity of 24.45% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	14.94%	17.33%	8.18%
Agilent Technologies	19.53%	24.45%	13.09%

Thermo Fisher Scientific presently has a consensus price target of $683.64, indicating a potential downside of 2.27%. Agilent Technologies has a consensus price target of $181.45, indicating a potential upside of 4.77%. Given Agilent Technologies' higher possible upside, analysts plainly believe Agilent Technologies is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	2 Strong Buy rating(s)	2.93
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.82

Summary

Thermo Fisher Scientific beats Agilent Technologies on 11 of the 20 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Thermo Fisher Scientific (NYSE:TMO) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Thermo Fisher Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.82	$6.70B	$18.96	36.90
AMN Healthcare Services	$2.73B	0.53	-$95.70M	$2.75	13.65

Thermo Fisher Scientific has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market.

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Thermo Fisher Scientific had 15 more articles in the media than AMN Healthcare Services. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 21 mentions for AMN Healthcare Services. Thermo Fisher Scientific's average media sentiment score of 1.29 beat AMN Healthcare Services' score of 0.52 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	28 Very Positive mention(s)	6 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AMN Healthcare Services	5 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific has a net margin of 14.94% compared to AMN Healthcare Services' net margin of 3.10%. AMN Healthcare Services' return on equity of 23.42% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	14.94%	17.33%	8.18%
AMN Healthcare Services	3.10%	23.42%	7.19%

Thermo Fisher Scientific currently has a consensus price target of $683.64, indicating a potential downside of 2.27%. AMN Healthcare Services has a consensus price target of $39.17, indicating a potential upside of 4.32%. Given AMN Healthcare Services' higher possible upside, analysts plainly believe AMN Healthcare Services is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	2 Strong Buy rating(s)	2.93
AMN Healthcare Services	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Thermo Fisher Scientific beats AMN Healthcare Services on 13 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Thermo Fisher Scientific (NYSE:TMO) and Bio-Rad Laboratories (NYSE:BIO) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by company insiders. Comparatively, 30.3% of Bio-Rad Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Thermo Fisher Scientific had 25 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 11 mentions for Bio-Rad Laboratories. Thermo Fisher Scientific's average media sentiment score of 1.29 beat Bio-Rad Laboratories' score of 0.33 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	28 Very Positive mention(s)	6 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Rad Laboratories	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Thermo Fisher Scientific currently has a consensus target price of $683.64, suggesting a potential downside of 2.27%. Bio-Rad Laboratories has a consensus target price of $366.67, suggesting a potential downside of 1.01%. Given Bio-Rad Laboratories' higher possible upside, analysts plainly believe Bio-Rad Laboratories is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	2 Strong Buy rating(s)	2.93
Bio-Rad Laboratories	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Thermo Fisher Scientific has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, Bio-Rad Laboratories has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market.

Thermo Fisher Scientific has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.82	$6.70B	$18.96	36.90
Bio-Rad Laboratories	$2.58B	3.83	$759.90M	$37.97	9.76

Bio-Rad Laboratories has a net margin of 39.45% compared to Thermo Fisher Scientific's net margin of 14.94%. Thermo Fisher Scientific's return on equity of 17.33% beat Bio-Rad Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	14.94%	17.33%	8.18%
Bio-Rad Laboratories	39.45%	3.58%	2.51%

Summary

Thermo Fisher Scientific beats Bio-Rad Laboratories on 12 of the 17 factors compared between the two stocks.

Get Thermo Fisher Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMO vs. The Competition

Export

Metric	Thermo Fisher Scientific	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$259.36B	$11.00B	$7.86B	$23.55B
Dividend Yield	0.26%	1.45%	2.46%	3.74%
P/E Ratio	36.92	52.35	34.60	29.91
Price / Sales	5.82	8.14	8.89	3.42
Price / Cash	23.61	27.09	22.23	15.68
Price / Book	4.74	4.59	4.40	3.72
Net Income	$6.70B	$57.48B	$3.51B	$1.08B
7 Day Performance	0.73%	-0.09%	-1.50%	0.61%
1 Month Performance	5.50%	0.46%	-3.92%	-0.29%
1 Year Performance	20.65%	20.11%	0.90%	6.82%

Thermo Fisher Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMO Thermo Fisher Scientific	3.6962 of 5 stars	$699.98 +0.1%	$683.64 -2.3%	+18.9%	$259.36B	$44.56B	36.92	125,000	Trending News
ILMN Illumina	3.0846 of 5 stars	$226.58 -4.0%	$244.24 +7.8%	+71.8%	$34.21B	$4.54B	39.00	8,650	Trending News Insider Trade
MEDP Medpace	2.6369 of 5 stars	$648.14 -0.6%	$649.27 +0.2%	+9.9%	$18.13B	$2.84B	35.93	6,200	Positive News
A Agilent Technologies	3.9102 of 5 stars	$172.01 -1.6%	$181.45 +5.5%	+14.3%	$48.49B	$6.95B	33.86	18,100
AMN AMN Healthcare Services	2.0572 of 5 stars	$45.87 -2.6%	$36.50 -20.4%	+126.6%	$1.78B	$2.73B	17.12	2,664

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TMO) was last updated on 11/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thermo Fisher Scientific (TMO) Competitors

TMO vs. ILMN, MEDP, A, AMN, and BIO

How does Thermo Fisher Scientific compare to Illumina?

Summary

How does Thermo Fisher Scientific compare to Medpace?

Summary

How does Thermo Fisher Scientific compare to Agilent Technologies?

Summary

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Summary

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO vs. The Competition

Thermo Fisher Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Thermo Fisher Scientific (TMO) Competitors

TMO vs. ILMN, MEDP, A, AMN, and BIO

How does Thermo Fisher Scientific compare to Illumina?

Does the media prefer TMO or ILMN?

Do analysts prefer TMO or ILMN?

Is TMO or ILMN more profitable?

Do institutionals & insiders have more ownership in TMO or ILMN?

Which has preferable valuation and earnings, TMO or ILMN?

Which has more risk & volatility, TMO or ILMN?

Summary

How does Thermo Fisher Scientific compare to Medpace?

Does the media prefer TMO or MEDP?

Do analysts recommend TMO or MEDP?

Which has more volatility and risk, TMO or MEDP?

Is TMO or MEDP more profitable?

Do insiders & institutionals believe in TMO or MEDP?

Which has better earnings & valuation, TMO or MEDP?

Summary

How does Thermo Fisher Scientific compare to Agilent Technologies?

Which has more volatility and risk, TMO or A?

Does the media refer more to TMO or A?

Do insiders and institutionals have more ownership in TMO or A?

Which has stronger valuation & earnings, TMO or A?

Is TMO or A a better dividend stock?

Is TMO or A more profitable?

Do analysts rate TMO or A?

Summary

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Which has higher valuation & earnings, TMO or AMN?

Which has more risk & volatility, TMO or AMN?

Do insiders and institutionals believe in TMO or AMN?

Does the media prefer TMO or AMN?

Is TMO or AMN more profitable?

Do analysts prefer TMO or AMN?

Summary

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Do insiders and institutionals have more ownership in TMO or BIO?

Does the media prefer TMO or BIO?

Do analysts prefer TMO or BIO?

Which has more risk & volatility, TMO or BIO?

Which has preferable valuation & earnings, TMO or BIO?

Is TMO or BIO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO vs. The Competition

Thermo Fisher Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools